The DOI matches its Crossref record; 210 of the 210 references it cites were found in a registry or an index.
DNA mismatch repair in cancer
Abstract
Microsatellite instability (MSI) refers to the hypermutator phenotype secondary to frequent polymorphism in short repetitive DNA sequences and single nucleotide substitution, as consequence of DNA mismatch repair (MMR) deficiency. MSI secondary to germline mutation in DNA MMR proteins is the molecular fingerprint of Lynch syndrome (LS), while epigenetic inactivation of these genes is more commonly found in sporadic MSI tumors. MSI occurs at different frequencies across malignancies, although original methods to assess MSI or MMR deficiency have been developed mostly in LS related cancers. Here we will discuss the current methods to detect MSI/MMR deficiency with a focus of new tools which are emerging as highly sensitive detector for MSI across multiple tumor types. Due to high frequencies of non‐synonymous mutations, the presence of frameshift‐mutated neoantigens, which can trigger a more robust and long‐lasting immune response and strong TIL infiltration with tumor eradication, MSI has emerged as an important predictor of sensitivity for immunotherapy‐based strategies, as showed by the recent FDA's first histology agnostic‐accelerated approval to immune checkpoint inhibitors for refractory, adult and pediatric, MMR deficient (dMMR) or MSI high (MSI‐H) tumors. Moreover, it is known that MSI status may predict cancer response/resistance to certain chemotherapies. Here we will describe the complex interplay between the genetic and clinical‐pathological features of MSI/dMMR tumors and the cancer immunotherapy, with a focus on the predictive and prognostic role of MMR status for immune checkpoint inhibitors (ICIs) and providing some suggestions on how to conceive better predictive markers for immunotherapy in the next future.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The blockade of immune checkpoints in cancer immunotherapy
Pardoll, D. M. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3239 · Cited by 13,838
Safety, activity, and immune correlates of anti–PD-1 antibody in cancer
Topalian, S. L., Hodi, F. S., Brahmer, J. R., Gettinger, S. N., Smith, D. C., McDermott, D. F., Powderly, J. D., Carvajal, R. D., Sosman, J. A., Atkins, M. B., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200690 · Cited by 12,628
A genetic model for colorectal tumorigenesis
Fearon, E. R., & Vogelstein, B. (1990) · Cell · doi:10.1016/0092-8674(90)90186-i · Cited by 12,132
Mutations of the BRAF gene in human cancer
Davies, H., Bignell, G. R., Cox, C., Stephens, P., Edkins, S., Clegg, S., Teague, J., Woffendin, H., Garnett, M. J., Bottomley, W., et al. (2002) · Nature · doi:10.1038/nature00766 · Cited by 10,674
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
Le, D. T., Uram, J. N., Wang, H., Bartlett, B. R., Kemberling, H., Eyring, A. D., Skora, A. D., Luber, B. S., Azad, N. S., Laheru, D., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1500596 · Cited by 9,377
Self-citationComprehensive molecular characterization of human colon and rectal cancer
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11252 · Cited by 8,499
Safety and activity of anti-PD-L1 antibody in patients with advanced cancer
Brahmer, J. R., Tykodi, S. S., Chow, L. Q. M., Hwu, W.-J., Topalian, S. L., Hwu, P., Drake, C. G., Camacho, L. H., Kauh, J., Odunsi, K., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200694 · Cited by 7,945
Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer
Rizvi, N. A., Hellmann, M. D., Snyder, A., Kvistborg, P., Makarov, V., Havel, J. J., Lee, W., Yuan, J., Wong, P., Ho, T. S., et al. (2015) · Science · doi:10.1126/science.aaa1348 · Cited by 7,802
Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
Le, D. T., Durham, J. N., Smith, K. N., Wang, H., Bartlett, B. R., Aulakh, L. K., Lu, S., Kemberling, H., Wilt, C., Luber, B. S., et al. (2017) · Science · doi:10.1126/science.aan6733 · Cited by 6,645
Self-citationComprehensive molecular characterization of gastric adenocarcinoma
The Cancer Genome Atlas Research Network (2014) · Nature · doi:10.1038/nature13480 · Cited by 6,498
Integrated genomic characterization of endometrial carcinoma
The Cancer Genome Atlas Research Network, & Levine, D. A. (2013) · Nature · doi:10.1038/nature12113 · Cited by 5,784
Comprehensive molecular profiling of lung adenocarcinoma
The Cancer Genome Atlas Research Network (2014) · Nature · doi:10.1038/nature13385 · Cited by 5,732
Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
Dong, H., Strome, S. E., Salomao, D. R., Tamura, H., Hirano, F., Flies, D. B., Roche, P. C., Lu, J., Zhu, G., Tamada, K., et al. (2002) · Nature Medicine · doi:10.1038/nm730 · Cited by 5,025
Neoantigens in cancer immunotherapy
Schumacher, T. N., & Schreiber, R. D. (2015) · Science · doi:10.1126/science.aaa4971 · Cited by 4,783
Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma
Snyder, A., Makarov, V., Merghoub, T., Yuan, J., Zaretsky, J. M., Desrichard, A., Walsh, L. A., Postow, M. A., Wong, P., Ho, T. S., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1406498 · Cited by 4,286
Boland, C. R., Thibodeau, S. N., Hamilton, S. R., Sidransky, D., Eshleman, J. R., Burt, R. W., Meltzer, S. J., Rodrı́guez-Bigas, M. A., Fodde, R., Ranzani, G. N., et al. (1998) · PubMed · Cited by 4,087
Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden
Chalmers, Z. R., Connelly, C. F., Fabrizio, D., Gay, L., Ali, S. M., Ennis, R., Schrock, A., Campbell, B., Shlien, A., Chmielecki, J., et al. (2017) · Genome Medicine · doi:10.1186/s13073-017-0424-2 · Cited by 3,519
ESMO consensus guidelines for the management of patients with metastatic colorectal cancer
Van Cutsem, E., Cervantes, A., Adam, R., Sobrero, A., Van Krieken, J. H., Aderka, D., Aranda Aguilar, E., Bardelli, A., Benson, A., Bodoky, G., et al. (2016) · Annals of Oncology · doi:10.1093/annonc/mdw235 · Cited by 3,421
Umar, A., Boland, C. R., Terdiman, J. P., Syngal, S., Chapelle, A. D. L., Ruschoff, J., Fishel, R., Lindor, N. M., Burgart, L. J., Hamelin, R., et al. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh034 · Cited by 3,183
Microsatellite Instability in Cancer of the Proximal Colon
Thibodeau, S. N., Bren, G., & Schaid, D. (1993) · Science · doi:10.1126/science.8484122 · Cited by 3,130
The prognostic landscape of genes and infiltrating immune cells across human cancers
Gentles, A. J., Newman, A. M., Liu, C. L., Bratman, S. V., Feng, W., Kim, D., Nair, V. S., Xu, Y., Khuong, A., Hoang, C. D., et al. (2015) · Nature Medicine · doi:10.1038/nm.3909 · Cited by 3,118
Patterns of somatic mutation in human cancer genomes
Greenman, C., Stephens, P., Smith, R., Dalgliesh, G. L., Hunter, C., Bignell, G., Davies, H., Teague, J., Butler, A., Stevens, C., et al. (2007) · Nature · doi:10.1038/nature05610 · Cited by 3,080
The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer
Fishel, R., Lescoe, M. K., Rao, M. R. S., Copeland, N. G., Jenkins, N. A., Garber, J., Kane, M., & Kolodner, R. (1993) · Cell · doi:10.1016/0092-8674(93)90546-3 · Cited by 2,873
Overman, M. J., McDermott, R., Leach, J. L., Lonardi, S., Lenz, H.-J., Morse, M. A., Desai, J., Hill, A., Axelson, M., Moss, R. A., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30422-9 · Cited by 2,836
Nishimura, H., Nose, M., Hiai, H., Minato, N., & Honjo, T. (1999) · Immunity · doi:10.1016/s1074-7613(00)80089-8 · Cited by 2,749
Clues to the Pathogenesis of Familial Colorectal Cancer
Aaltonen, L. A., Peltomäki, P., Leach, F. S., Sistonen, P., Pylkkänen, L., Mecklin, J.-P., Järvinen, H., Powell, S. M., Jen, J., Hamilton, S. R., et al. (1993) · Science · doi:10.1126/science.8484121 · Cited by 2,710
Ionov, Y., Peinado, M. A., Malkhosyan, S., Shibata, D., & Perucho, M. (1993) · Nature · doi:10.1038/363558a0 · Cited by 2,708
Topoisomerase I inhibitors: camptothecins and beyond
Pommier, Y. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1977 · Cited by 2,277
Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer
Leach, F. S., Nicolaides, N. C., Papadopoulos, N., Liu, B., Jen, J., Parsons, R., Peltomäki, P., Sistonen, P., Aaltonen, L. A., Nyström-Lahti, M., et al. (1993) · Cell · doi:10.1016/0092-8674(93)90330-s · Cited by 2,276
Lynch, H. T., & de la Chapelle, A. (2003) · New England Journal of Medicine · doi:10.1056/nejmra012242 · Cited by 2,203
Ribic, C. M., Sargent, D. J., Moore, M. J., Thibodeau, S. N., French, A. J., Goldberg, R. M., Hamilton, S. R., Laurent-Puig, P., Gryfe, R., Shepherd, L. E., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022289 · Cited by 2,160
The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC)
Vasen, H. F. A., Mecklin, J. P., Meera Khan, P., & Lynch, H. T. (1991) · Diseases of the Colon & Rectum · doi:10.1007/bf02053699 · Cited by 2,147
Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT)
Cheng, D. T., Mitchell, T. N., Zehir, A., Shah, R. H., Benayed, R., Syed, A., Chandramohan, R., Liu, Z. Y., Won, H. H., Scott, S. N., et al. (2015) · The Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2014.12.006 · Cited by 2,119
Overman, M. J., Lonardi, S., Wong, K. Y. M., Lenz, H.-J., Gelsomino, F., Aglietta, M., Morse, M. A., Van Cutsem, E., McDermott, R., Hill, A., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2017.76.9901 · Cited by 2,079
Weisenberger, D. J., Siegmund, K. D., Campan, M., Young, J., Long, T. I., Faasse, M. A., Kang, G. H., Widschwendter, M., Weener, D., Buchanan, D., et al. (2006) · Nature Genetics · doi:10.1038/ng1834 · Cited by 1,990
Drake, J. W., Charlesworth, B., Charlesworth, D., & Crow, J. F. (1998) · Genetics · doi:10.1093/genetics/148.4.1667 · Cited by 1,932
Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma
Herman, J. G., Umar, A., Polyak, K., Graff, J. R., Ahuja, N., Issa, J.-P. J., Markowitz, S., Willson, J. K. V., Hamilton, S. R., Kinzler, K. W., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.12.6870 · Cited by 1,887
Mutation of a mutL Homolog in Hereditary Colon Cancer
Papadopoulos, N., Nicolaides, N. C., Wei, Y.-F., Ruben, S. M., Carter, K. C., Rosen, C. A., Haseltine, W. A., Fleischmann, R. D., Fraser, C. M., Adams, M. D., et al. (1994) · Science · doi:10.1126/science.8128251 · Cited by 1,834
Systematic Review of Microsatellite Instability and Colorectal Cancer Prognosis
Popat, S., Hubner, R., & Houlston, R. S. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.086 · Cited by 1,830
Seiwert, T. Y., Burtness, B., Mehra, R., Weiss, J., Berger, R., Eder, J. P., Heath, K., McClanahan, T., Lunceford, J., Gause, C., et al. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(16)30066-3 · Cited by 1,745
Sargent, D. J., Marsoni, S., Monges, G., Thibodeau, S. N., Labianca, R., Hamilton, S. R., French, A. J., Kabat, B., Foster, N. R., Torri, V., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.1825 · Cited by 1,623
Inhibitory B7-family molecules in the tumour microenvironment
Zou, W., & Chen, L. (2008) · Nature Reviews Immunology · doi:10.1038/nri2326 · Cited by 1,608
Mutations of two P/WS homologues in hereditary nonpolyposis colon cancer
Nicolaides, N. C., Papadopoulos, N., Liu, B., Weit, Y.-F., Carter, K. C., Ruben, S. M., Rosen, C. A., Haseltine, W. A., Fleischmann, R. D., Fraser, C. M., et al. (1994) · Nature · doi:10.1038/371075a0 · Cited by 1,545
Llosa, N. J., Cruise, M., Tam, A., Wicks, E. C., Hechenbleikner, E. M., Taube, J. M., Blosser, R. L., Fan, H., Wang, H., Luber, B. S., et al. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-0863 · Cited by 1,487
Mechanisms and functions of DNA mismatch repair
Li, G.-M. (2008) · Cell Research · doi:10.1038/cr.2007.115 · Cited by 1,487
Landscape of Microsatellite Instability Across 39 Cancer Types
Bonneville, R., Krook, M. A., Kautto, E. A., Miya, J., Wing, M. R., Chen, H.-Z., Reeser, J. W., Yu, L., & Roychowdhury, S. (2017) · JCO Precision Oncology · doi:10.1200/po.17.00073 · Cited by 1,476
Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer)
Hampel, H., Frankel, W. L., Martin, E., Arnold, M., Khanduja, K., Kuebler, P., Nakagawa, H., Sotamaa, K., Prior, T. W., Westman, J., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043146 · Cited by 1,408
Tumor Microsatellite Instability and Clinical Outcome in Young Patients with Colorectal Cancer
Gryfe, R., Kim, H., Hsieh, E. T. K., Aronson, M. D., Holowaty, E. J., Bull, S. B., Redston, M., & Gallinger, S. (2000) · New England Journal of Medicine · doi:10.1056/nejm200001133420201 · Cited by 1,388
The multifaceted mismatch-repair system
Jiricny, J. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1907 · Cited by 1,370
Kunkel, T. A., & Erie, D. A. (2005) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.74.082803.133243 · Cited by 1,367
Primary Resistance to PD-1 Blockade Mediated by JAK1/2 Mutations
Shin, D. S., Zaretsky, J. M., Escuin-Ordinas, H., Garcia-Diaz, A., Hu-Lieskovan, S., Kalbasi, A., Grasso, C. S., Hugo, W., Sandoval, S., Torrejon, D. Y., et al. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-1223 · Cited by 1,337
Self-citationTargeting the PD-1/B7-H1(PD-L1) pathway to activate anti-tumor immunity
Topalian, S. L., Drake, C. G., & Pardoll, D. M. (2012) · Current Opinion in Immunology · doi:10.1016/j.coi.2011.12.009 · Cited by 1,329
Genomic spectra of biliary tract cancer
Nakamura, H., Arai, Y., Totoki, Y., Shirota, T., Elzawahry, A., Kato, M., Hama, N., Hosoda, F., Urushidate, T., Ohashi, S., et al. (2015) · Nature Genetics · doi:10.1038/ng.3375 · Cited by 1,284
Hereditary cancer, oncogenes, and antioncogenes.
Knudson, A. G. (1985) · PubMed · Cited by 1,218
Aaltonen, L. A., Salovaara, R., Kristo, P., Canzian, F., Hemminki, A., Peltomäki, P., Chadwick, R. B., Kääriäinen, H., Eskelinen, M., Järvinen, H., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199805213382101 · Cited by 1,152
Cairns, S. R., Scholefield, J. H., Steele, R. J., Dunlop, M. G., Thomas, H. J. W., Evans, G. D., Eaden, J. A., Rutter, M. D., Atkin, W. P., Saunders, B. P., et al. (2010) · Gut · doi:10.1136/gut.2009.179804 · Cited by 1,141
Microsatellite Instability in Colorectal Cancer-the Stable Evidence
Vilar, E., & Gruber, S. B. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2009.237 · Cited by 1,063
Mlecnik, B., Bindea, G., Angell, H. K., Maby, P., Angelova, M., Tougeron, D., Church, S. E., Lafontaine, L., Fischer, M., Fredriksen, T., et al. (2016) · Immunity · doi:10.1016/j.immuni.2016.02.025 · Cited by 1,034
Targeting neoantigens to augment antitumour immunity
Yarchoan, M., Johnson, B. A., Lutz, E. R., Laheru, D. A., & Jaffee, E. M. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2016.154 · Cited by 997
Classification and characterization of microsatellite instability across 18 cancer types
Hause, R. J., Pritchard, C. C., Shendure, J., & Salipante, S. J. (2016) · Nature Medicine · doi:10.1038/nm.4191 · Cited by 991
Analysis of mismatch repair genes in hereditary non–polyposis colorectal cancer patients
Liu, B., Parsons, R., Papadopoulos, N., Nicolaides, N. C., Lynch, H. T., Watson, P., Jass, J. R., Dunlop, M., Wyllie, A., Peltomäki, P., et al. (1996) · Nature Medicine · doi:10.1038/nm0296-169 · Cited by 945
Microsatellite Instability as a Biomarker for PD-1 Blockade
Dudley, J. C., Lin, M.-T., Le, D. T., & Eshleman, J. R. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-1678 · Cited by 931
Self-citationBouffet, E., Larouche, V., Campbell, B. B., Merico, D., de Borja, R., Aronson, M., Durno, C., Krueger, J., Cabric, V., Ramaswamy, V., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.66.6552 · Cited by 857
MSIsensor: microsatellite instability detection using paired tumor-normal sequence data
Niu, B., Ye, K., Zhang, Q., Lu, C., Xie, M., McLellan, M. D., Wendl, M. C., & Ding, L. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btt755 · Cited by 832
Ligtenberg, M. J. L., Kuiper, R. P., Chan, T. L., Goossens, M., Hebeda, K. M., Voorendt, M., Lee, T. Y. H., Bodmer, D., Hoenselaar, E., Hendriks-Cornelissen, S. J. B., et al. (2009) · Nature Genetics · doi:10.1038/ng.283 · Cited by 818
Genetic susceptibility to non-polyposis colorectal cancer
Lynch, H. T., & de la Chapelle, A. (1999) · Journal of Medical Genetics · doi:10.1136/jmg.36.11.801 · Cited by 814
Comprehensive Analysis of Hypermutation in Human Cancer
Campbell, B. B., Light, N., Fabrizio, D., Zatzman, M., Fuligni, F., de Borja, R., Davidson, S., Edwards, M., Elvin, J. A., Hodel, K. P., et al. (2017) · Cell · doi:10.1016/j.cell.2017.09.048 · Cited by 765
Howitt, B. E., Shukla, S. A., Sholl, L. M., Ritterhouse, L. L., Watkins, J. C., Rodig, S., Stover, E., Strickland, K. C., D’Andrea, A. D., Wu, C. J., et al. (2015) · JAMA Oncology · doi:10.1001/jamaoncol.2015.2151 · Cited by 684
André, T., de Gramont, A., Vernerey, D., Chibaudel, B., Bonnetain, F., Tijeras-Raballand, A., Scriva, A., Hickish, T., Tabernero, J., Van Laethem, J. L., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.63.4238 · Cited by 683
Hutchins, G., Southward, K., Handley, K., Magill, L., Beaumont, C., Stahlschmidt, J., Richman, S., Chambers, P., Seymour, M., Kerr, D., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.1366 · Cited by 681
A molecular portrait of microsatellite instability across multiple cancers
Cortes-Ciriano, I., Lee, S., Park, W.-Y., Kim, T.-M., & Park, P. J. (2017) · Nature Communications · doi:10.1038/ncomms15180 · Cited by 658
Shia, J. (2008) · The Journal of Molecular Diagnostics · doi:10.2353/jmoldx.2008.080031 · Cited by 643
Inactivation of DNA repair triggers neoantigen generation and impairs tumour growth
Germano, G., Lamba, S., Rospo, G., Barault, L., Magrì, A., Maione, F., Russo, M., Crisafulli, G., Bartolini, A., Lerda, G., et al. (2017) · Nature · doi:10.1038/nature24673 · Cited by 627
Suraweera, N., Duval, A., Reperant, M., Vaury, C., Furlan, D., Leroy, K., Seruca, R., Iacopetta, B., & Hamelin, R. (2002) · Gastroenterology · doi:10.1053/gast.2002.37070 · Cited by 620
Ilie, M., Long-Mira, E., Bence, C., Butori, C., Lassalle, S., Bouhlel, L., Fazzalari, L., Zahaf, K., Lalvée, S., Washetine, K., et al. (2016) · Annals of Oncology · doi:10.1093/annonc/mdv489 · Cited by 587
Identification of Lynch Syndrome Among Patients With Colorectal Cancer
Moreira, L., Balaguer, F., Lindor, N., de la Chapelle, A., Hampel, H., Aaltonen, L. A., Hopper, J. L., Le Marchand, L., Gallinger, S., Newcomb, P. A., et al. (2012) · JAMA · doi:10.1001/jama.2012.13088 · Cited by 556
Sinicrope, F. A., Foster, N. R., Thibodeau, S. N., Marsoni, S., Monges, G., Labianca, R., Yothers, G., Allegra, C., Moore, M. J., Gallinger, S., et al. (2011) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djr153 · Cited by 543
Smyth, E. C., Wotherspoon, A., Peckitt, C., Gonzalez, D., Hulkki-Wilson, S., Eltahir, Z., Fassan, M., Rugge, M., Valeri, N., Okines, A., et al. (2017) · JAMA Oncology · doi:10.1001/jamaoncol.2016.6762 · Cited by 521
Identification of an Alternative CTLA-4 Ligand Costimulatory for T Cell Activation
Hathcock, K. S., Laszlo, G., Dickler, H. B., Bradshaw, J., Linsley, P., & Hodes, R. J. (1993) · Science · doi:10.1126/science.7694361 · Cited by 517
Population-Based Molecular Detection of Hereditary Nonpolyposis Colorectal Cancer
Salovaara, R., Loukola, A., Kristo, P., Kääriäinen, H., Ahtola, H., Eskelinen, M., Härkönen, N., Julkunen, R., Kangas, E., Ojala, S., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.11.2193 · Cited by 516
Deficient mismatch repair system in patients with sporadic advanced colorectal cancer
Koopman, M., Kortman, G. A. M., Mekenkamp, L., Ligtenberg, M. J. L., Hoogerbrugge, N., Antonini, N. F., Punt, C. J. A., & van Krieken, J. H. J. M. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6604867 · Cited by 515
Karran, P., & Attard, N. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2292 · Cited by 477
Palomaki, G. E., McClain, M. R., Melillo, S., Hampel, H. L., & Thibodeau, S. N. (2009) · Genetics in Medicine · doi:10.1097/gim.0b013e31818fa2db · Cited by 467
Microsatellite Instability and BRAF Mutation Testing in Colorectal Cancer Prognostication
Lochhead, P., Kuchiba, A., Imamura, Y., Liao, X., Yamauchi, M., Nishihara, R., Qian, Z. R., Morikawa, T., Shen, J., Meyerhardt, J. A., et al. (2013) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djt173 · Cited by 442
Hunter, C., Smith, R., Cahill, D. P., Stephens, P., Stevens, C., Teague, J., Greenman, C., Edkins, S., Bignell, G., Davies, H., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0127 · Cited by 434
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
(2015) · New England Journal of Medicine · doi:10.1056/nejmc1510353 · Cited by 426
Genschel, J., Littman, S. J., Drummond, J. T., & Modrich, P. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.31.19895 · Cited by 422
Epitope Landscape in Breast and Colorectal Cancer
Segal, N. H., Parsons, D. W., Peggs, K. S., Velculescu, V., Kinzler, K. W., Vogelstein, B., & Allison, J. P. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-3095 · Cited by 416
Yuen, S. T., Davies, H. R., Chan, T. L., Ho, J. W. C., Bignell, G. R., Cox, C., Stephens, P., Edkins, S., Tsui, W. W., Chan, A. S. Y., et al. (2002) · PubMed · Cited by 404
Hodges, T. R., Ott, M., Xiu, J., Gatalica, Z., Swensen, J., Zhou, S., Huse, J. T., de Groot, J., Li, S., Overwijk, W. W., et al. (2017) · Neuro-Oncology · doi:10.1093/neuonc/nox026 · Cited by 404
Samowitz, W. S., Curtin, K., Ma, K., Schaffer, D., Coleman, L. W., Leppert, M., & Slattery, M. L. (2001) · PubMed · Cited by 401
Microsatellite Instability Detection by Next Generation Sequencing
Salipante, S. J., Scroggins, S. M., Hampel, H. L., Turner, E. H., & Pritchard, C. C. (2014) · Clinical Chemistry · doi:10.1373/clinchem.2014.223677 · Cited by 399
Wijnen, J. T., Vasen, H. F. A., Khan, P. M., Zwinderman, A. H., van der Klift, H., Mulder, A., Tops, C., Møller, P., Fodde, R., Menko, F., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199808203390804 · Cited by 396
Prediction of Germline Mutations and Cancer Risk in the Lynch Syndrome
Chen, S., Wang, W., Lee, S., Nafa, K., Lee, J., Romans, K., Watson, P., Gruber, S. B., Euhus, D., Kinzler, K. W., et al. (2006) · JAMA · doi:10.1001/jama.296.12.1479 · Cited by 384
The Landscape of Microsatellite Instability in Colorectal and Endometrial Cancer Genomes
Kim, T.-M., Laird, P. W., & Park, P. J. (2013) · Cell · doi:10.1016/j.cell.2013.10.015 · Cited by 380
Guastadisegni, C., Colafranceschi, M., Ottini, L., & Dogliotti, E. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.05.009 · Cited by 380
Middha, S., Zhang, L., Nafa, K., Jayakumaran, G., Wong, D., Kim, H. R., Sadowska, J., Berger, M. F., Delair, D. F., Shia, J., et al. (2017) · JCO Precision Oncology · doi:10.1200/po.17.00084 · Cited by 377
Haraldsdottir, S., Hampel, H., Tomsic, J., Frankel, W. L., Pearlman, R., de la Chapelle, A., & Pritchard, C. C. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.08.041 · Cited by 376
for the Biallelic Mismatch Repair Deficiency Consortium, Shlien, A., Campbell, B. B., de Borja, R., Alexandrov, L. B., Merico, D., Wedge, D., Van Loo, P., Tarpey, P. S., Coupland, P., et al. (2015) · Nature Genetics · doi:10.1038/ng.3202 · Cited by 374
Bertagnolli, M. M., Niedzwiecki, D., Compton, C. C., Hahn, H. P., Hall, M., Damas, B., Jewell, S. D., Mayer, R. J., Goldberg, R. M., Saltz, L. B., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.2071 · Cited by 364
Calculation of risk of colorectal and endometrial cancer among patients with Lynch syndrome
Stoffel, E., Mukherjee, B., Raymond, V. M., Tayob, N., Kastrinos, F., Sparr, J., Wang, F., Bandipalliam, P., Syngal, S., & Gruber, S. B. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.07.039 · Cited by 360
Microsatellite Instability: A Predictive Biomarker for Cancer Immunotherapy
Chang, L., Chang, M., Chang, H. M., & Chang, F. (2018) · Applied Immunohistochemistry & Molecular Morphology · doi:10.1097/pai.0000000000000575 · Cited by 345
Kim, G. P., Colangelo, L. H., Wieand, H. S., Paik, S., Kirsch, I. R., Wolmark, N., & Allegra, C. J. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.05.8172 · Cited by 342
Practical guidance for mismatch repair-deficiency testing in endometrial cancer
Stelloo, E., Jansen, A. M. L., Osse, E. M., Nout, R. A., Creutzberg, C. L., Ruano, D., Church, D. N., Morreau, H., Smit, V. T. H. B. M., van Wezel, T., et al. (2017) · Annals of Oncology · doi:10.1093/annonc/mdw542 · Cited by 342
Ladabaum, U., Wang, G., Terdiman, J., Blanco, A., Kuppermann, M., Boland, C. R., Ford, J., Elkin, E., & Phillips, K. A. (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-155-2-201107190-00002 · Cited by 340
BRAF screening as a low-cost effective strategy for simplifying HNPCC genetic testing
Domingo, E., Laiho, P., Ollikainen, M., Pinto, M., Wang, L., French, A. J., Westra, J., Frebourg, T., Espín, E., Armengol, M., et al. (2004) · Journal of Medical Genetics · doi:10.1136/jmg.2004.020651 · Cited by 339
Clinical Relevance of Microsatellite Instability in Colorectal Cancer
de la Chapelle, A., & Hampel, H. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.0652 · Cited by 332
Germ-line msh6 mutations in colorectal cancer families.
Kolodner, R. D., Tytell, J. D., Schmeits, J. L., Kane, M., Gupta, R. D., Weger, J., Wahlberg, S., Fox, E. A., Peel, D. A., Ziogas, A., et al. (1999) · PubMed · Cited by 324
Gavin, P. G., Colangelo, L. H., Fumagalli, D., Tanaka, N., Remillard, M. Y., Yothers, G., Kim, C., Taniyama, Y., Kim, S. I., Choi, H. J., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0605 · Cited by 320
Performance evaluation for rapid detection of pan-cancer microsatellite instability with MANTIS
Kautto, E. A., Bonneville, R., Miya, J., Yu, L., Krook, M. A., Reeser, J. W., & Roychowdhury, S. (2017) · Oncotarget · doi:10.18632/oncotarget.13918 · Cited by 316
Mvundura, M., Grosse, S. D., Hampel, H., & Palomaki, G. E. (2010) · Genetics in Medicine · doi:10.1097/gim.0b013e3181cd666c · Cited by 292
BRAF mutations in colon cancer are not likely attributable to defective DNA mismatch repair.
Wang, L., Cunningham, J. M., Winters, J. L., Guenther, J. C., French, A. J., Boardman, L. A., Burgart, L. J., McDonnell, S. K., Schaid, D. J., & Thibodeau, S. N. (2003) · PubMed · Cited by 282
Murphy, K. M., Zhang, S., Geiger, T., Hafez, M. J., Bacher, J., Berg, K. D., & Eshleman, J. R. (2006) · The Journal of Molecular Diagnostics · doi:10.2353/jmoldx.2006.050092 · Cited by 281
Development of a Fluorescent Multiplex Assay for Detection of MSI‐High Tumors
Bacher, J. W., Flanagan, L. A., Smalley, R. L., Nassif, N. A., Burgart, L. J., Halberg, R. B., Megid, W. M. A., & Thibodeau, S. N. (2004) · Disease Markers · doi:10.1155/2004/136734 · Cited by 276
Sæterdal, I., Bjørheim, J., Lislerud, K., Gjertsen, M. K., Bukholm, I. K., Olsen, O. C., Nesland, J. M., Eriksen, J. A., Møller, M., Lindblom, A., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.231326898 · Cited by 273
Li, Y., Liang, L., Dai, W., Cai, G., Xu, Y., Li, X., Li, Q., & Cai, S. (2016) · Molecular Cancer · doi:10.1186/s12943-016-0539-x · Cited by 270
Bebenek, K., & Kunkel, T. A. (2004) · Advances in Protein Chemistry · doi:10.1016/s0065-3233(04)69005-x · Cited by 258
Greenson, J. K., Bonner, J. D., Ben-Yzhak, O., Cohen, H. I., Miselevich, I., Resnick, M. B., Trougouboff, P., Tomsho, L. D., Kim, E., Low, M., et al. (2003) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200305000-00001 · Cited by 252
Prognostic significance of defective mismatch repair and BRAF V600E in patients with colon cancer
French, A. J., Sargent, D. J., Burgart, L. J., Foster, N. R., Kabat, B. F., Goldberg, R., Shepherd, L., Windschitl, H. E., & Thibodeau, S. N. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1489 · Cited by 251
Adam, R., Spier, I., Zhao, B., Kloth, M., Marquez, J., Hinrichsen, I., Kirfel, J., Tafazzoli, A., Horpaopan, S., Uhlhaas, S., et al. (2016) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2016.06.015 · Cited by 251
Microsatellite instability: an update
Yamamoto, H., & Imai, K. (2015) · Archives of Toxicology · doi:10.1007/s00204-015-1474-0 · Cited by 247
Mills, A. M., Liou, S., Ford, J. M., Berek, J. S., Pai, R. K., & Longacre, T. A. (2014) · American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000321 · Cited by 243
Timmermann, B., Kerick, M., Roehr, C., Fischer, A., Isau, M., Boerno, S. T., Wunderlich, A., Barmeyer, C., Seemann, P., Koenig, J., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015661 · Cited by 243
Frameshift peptide-derived T-cell epitopes: A source of novel tumor-specific antigens
Linnebacher, M., Gebert, J., Rudy, W., Woerner, S., Yuan, Y. P., Bork, P., & von Knebel Doeberitz, M. (2001) · International Journal of Cancer · doi:10.1002/ijc.1298 · Cited by 234
Bakry, D., Aronson, M., Durno, C., Rimawi, H., Farah, R., Alharbi, Q. K., Alharbi, M., Shamvil, A., Ben-Shachar, S., Mistry, M., et al. (2014) · European Journal of Cancer · doi:10.1016/j.ejca.2013.12.005 · Cited by 233
Tumour CD274 (PD-L1) expression and T cells in colorectal cancer
Masugi, Y., Nishihara, R., Yang, J., Mima, K., da Silva, A., Shi, Y., Inamura, K., Cao, Y., Song, M., Nowak, J. A., et al. (2017) · Gut · doi:10.1136/gutjnl-2016-311421 · Cited by 231
Prognostic Impact of Microsatellite Instability and DNA Ploidy in Human Colon Carcinoma Patients
Sinicrope, F. A., Rego, R. L., Halling, K. C., Foster, N., Sargent, D. J., La Plant, B., French, A. J., Laurie, J. A., Goldberg, R. M., Thibodeau, S. N., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.06.005 · Cited by 230
Cao, E., Zang, X., Ramagopal, U. A., Mukhopadhaya, A., Fedorov, A., Fedorov, E., Zencheck, W. D., Lary, J. W., Cole, J. L., Deng, H., et al. (2007) · Immunity · doi:10.1016/j.immuni.2007.01.016 · Cited by 228
Tabori, U., Hansford, J. R., Achatz, M. I., Kratz, C. P., Plon, S. E., Frebourg, T., & Brugières, L. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0574 · Cited by 227
Mismatch repair defects in human carcinogenesis
Eshleman, J. R., & Markowitz, S. D. (1996) · Human Molecular Genetics · doi:10.1093/hmg/5.supplement_1.1489 · Cited by 223
High prevalence of Foxp3 and IL17 in MMR-proficient colorectal carcinomas
Le Gouvello, S., Bastuji-Garin, S., Aloulou, N., Mansour, H., Chaumette, M.-T., Berrehar, F., Seikour, A., Charachon, A., Karoui, M., Leroy, K., et al. (2008) · Gut · doi:10.1136/gut.2007.123794 · Cited by 214
Zhang, L. (2008) · The Journal of Molecular Diagnostics · doi:10.2353/jmoldx.2008.080062 · Cited by 213
Zighelboim, I., Goodfellow, P. J., Gao, F., Gibb, R. K., Powell, M. A., Rader, J. S., & Mutch, D. G. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.2107 · Cited by 202
The molecular genetics of cervical carcinoma
Lazo, P. A. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690635 · Cited by 198
Barratt, P., Seymour, M., Stenning, S., Georgiades, I., Walker, C., Birbeck, K., & Quirke, P. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11402-4 · Cited by 194
Relevance, Pathogenesis, and Testing Algorithm for Mismatch Repair–Defective Colorectal Carcinomas
Funkhouser, W. K., Lubin, I. M., Monzon, F. A., Zehnbauer, B. A., Evans, J. P., Ogino, S., & Nowak, J. A. (2012) · The Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2011.11.001 · Cited by 189
Patterns and prognostic relevance of PD-1 and PD-L1 expression in colorectal carcinoma
Lee, L. H., Cavalcanti, M. S., Segal, N. H., Hechtman, J. F., Weiser, M. R., Smith, J. J., Garcia-Aguilar, J., Sadot, E., Ntiamoah, P., Markowitz, A. J., et al. (2016) · Modern Pathology · doi:10.1038/modpathol.2016.139 · Cited by 186
Testing guidelines for hereditary non-polyposis colorectal cancer
Umar, A., Risinger, J. I., Hawk, E. T., & Barrett, J. C. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1278 · Cited by 184
Dinh, T. A., Rosner, B. I., Atwood, J. C., Boland, C. R., Syngal, S., Vasen, H. F. A., Gruber, S. B., & Burt, R. W. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0262 · Cited by 175
Quasimonomorphic Mononucleotide Repeats for High‐Level Microsatellite Instability Analysis
Umar, A., Buhard, O., Suraweera, N., Lectard, A., Duval, A., & Hamelin, R. (2004) · Disease Markers · doi:10.1155/2004/159347 · Cited by 174
LAG3 limits regulatory T cell proliferation and function in autoimmune diabetes
Zhang, Q., Chikina, M., Szymczak-Workman, A. L., Horne, W., Kolls, J. K., Vignali, K. M., Normolle, D., Bettini, M., Workman, C. J., & Vignali, D. A. A. (2017) · Science Immunology · doi:10.1126/sciimmunol.aah4569 · Cited by 164
Detection of Microsatellite Instability by Fluorescence Multiplex Polymerase Chain Reaction
Berg, K. D., Glaser, C. L., Thompson, R. E., Hamilton, S. R., Griffin, C. A., & Eshleman, J. R. (2000) · The Journal of Molecular Diagnostics · doi:10.1016/s1525-1578(10)60611-3 · Cited by 163
Mathiak, M., Warneke, V. S., Behrens, H., Haag, J., Böger, C., Krüger, S., & Röcken, C. (2015) · Applied immunohistochemistry & molecular morphology · doi:10.1097/pai.0000000000000264 · Cited by 152
Hypermutated tumours in the era of immunotherapy: The paradigm of personalised medicine
Nebot-Bral, L., Brandão, D., Verlingue, L., Rouleau, É., Caron, O., Despras, E., Dakdouki, Y. E., Champiat, S., Aoufouchi, S., Leary, A. F., et al. (2017) · European Journal of Cancer · doi:10.1016/j.ejca.2017.07.026 · Cited by 151
Pal, T., Permuth‐Wey, J., Kumar, A., & Sellers, T. A. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1387 · Cited by 150
Mouradov, D., Domingo, E., Gibbs, P., Jorissen, R. N., Li, S., Soo, P. Y., Lipton, L. R., Desai, J., Danielsen, H. E., Oukrif, D., et al. (2013) · The American Journal of Gastroenterology · doi:10.1038/ajg.2013.292 · Cited by 150
Harnessing the Immunotherapy Revolution for the Treatment of Childhood Cancers
Majzner, R. G., Heitzeneder, S., & Mackall, C. L. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.03.002 · Cited by 150
Sloan, E. A., Ring, K. L., Willis, B. C., Modesitt, S. C., & Mills, A. M. (2016) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000783 · Cited by 146
MSIseq: Software for Assessing Microsatellite Instability from Catalogs of Somatic Mutations
Huang, M. N., McPherson, J. R., Cutcutache, I., Teh, B. T., Tan, P. B. O., & Rozen, S. (2015) · Scientific Reports · doi:10.1038/srep13321 · Cited by 142
Díaz-Padilla, I., Romero-Laorden, N., Amir, E., Matías‐Guiu, X., Vilar, E., Muggia, F. M., & García-Donás, J. (2013) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2013.03.002 · Cited by 142
Findeisen, P., Kloor, M., Merx, S., Sutter, C., Woerner, S. M., Dostmann, N., Benner, A., Dondog, B., Pawlita, M., Dippold, W. G., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4146 · Cited by 141
Understanding the CD28/CTLA-4 (CD152) Pathway and Its Implications for Costimulatory Blockade
Gardner, D. H., Jeffery, L. E., & Sansom, D. M. (2014) · American Journal of Transplantation · doi:10.1111/ajt.12834 · Cited by 139
Lin, K. M., Shashidharan, M., Thorson, A. G., Ternent, C. A., Blatchford, G. J., Christensen, M. A., Watson, P. A., Lemon, S. J., Franklin, B., Karr, B., et al. (1998) · Journal of Gastrointestinal Surgery · doi:10.1016/s1091-255x(98)80105-4 · Cited by 137
Constitutional mismatch repair deficiency syndrome: clinical description in a French cohort
Lavoine, N., Colas, C., Muleris, M., Bodo, S., Duval, A., Entz‐Werlé, N., Coulet, F., Cabaret, O., Andreiuolo, F. D. M., Charpy, C., et al. (2015) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2015-103299 · Cited by 136
Stiller, M., Knapp, M., Stenzel, U., Hofreiter, M., & Meyer, M. (2009) · Genome Research · doi:10.1101/gr.095760.109 · Cited by 135
Baudhuin, L. M., Burgart, L. J., Leontovich, O. N., & Thibodeau, S. N. (2005) · Familial Cancer · doi:10.1007/s10689-004-1447-6 · Cited by 129
Murphy, M., & Wentzensen, N. (2010) · International Journal of Cancer · doi:10.1002/ijc.25835 · Cited by 127
Ruemmele, P., Dietmaier, W., Terracciano, L., Tornillo, L., Bataille, F., Kaiser, A., Wuensch, P. H., Heinmoeller, E., Homayounfar, K., Luettges, J., et al. (2009) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3181983ef7 · Cited by 125
Kuismanen, S. A., Moisio, A., Schweizer, P., Truninger, K., Salovaara, R., Arola, J. T., Bützow, R. C., Jiricny, J., Nyström, M., & Peltomäki, P. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)61144-3 · Cited by 123
Cellular effects of CPT‐11 on colon carcinoma cells: Dependence on p53 and hMLH1 status
Magrini, R., Bhonde, M., Hanski, M., Notter, M., Scherübl, H., Boland, C. R., Zeitz, M., & HANSKI, C. (2002) · International Journal of Cancer · doi:10.1002/ijc.10565 · Cited by 121
Chromosomal Instability in Microsatellite-Unstable and Stable Colon Cancer
Trautmann, K., Terdiman, J. P., French, A. J., Roydasgupta, R., Sein, N., Kakar, S., Fridlyand, J., Snijders, A. M., Albertson, D. G., Thibodeau, S. N., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1248 · Cited by 112
Limitations and opportunities for immune checkpoint inhibitors in pediatric malignancies
Park, J. A., & Cheung, N. V. (2017) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2017.05.006 · Cited by 107
Mutator phenotypes due to DNA replication infidelity
Arana, M. E., & Kunkel, T. A. (2010) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2010.10.003 · Cited by 103
Verma, L., Kane, M., Brassett, C., Schmeits, J. L., Evans, D. G., Kolodner, R. D., & Maher, E. R. (1999) · Journal of Medical Genetics · doi:10.1136/jmg.36.9.678 · Cited by 101
Bodo, S., Colas, C., Buhard, O., Collura, A., Tinat, J., Lavoine, N., Guilloux, A., Chalastanis, A., Lafitte, P., Coulet, F., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.06.013 · Cited by 100
A meta-analysis of MSI frequency and race in colorectal cancer
Ashktorab, H., Ahuja, S., Kannan, L., Llor, X., Ellis, N. A., Xicola, R. M., Laiyemo, A. O., Carethers, J. M., Brim, H., & Nouraie, M. S. (2016) · Oncotarget · doi:10.18632/oncotarget.8945 · Cited by 99
DNA mismatch repair-related protein loss as a prognostic factor in endometrial cancers
Kato, M., Takano, M., Miyamoto, M., Sasaki, N., Gotō, T., Tsuda, H., & Furuya, K. (2015) · Journal of Gynecologic Oncology · doi:10.3802/jgo.2015.26.1.40 · Cited by 98
Vilar, E., Scaltriti, M., Balmañà, J., Saura, C., Guzmán, M., Arribas, J., Baselga, J. M., & Tabernero, J. M. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604691 · Cited by 98
The promise of PD-1 inhibitors in gastro-esophageal cancers: microsatellite instability vs. PD-L1
Jin, Z., & Yoon, H. H. (2016) · Journal of Gastrointestinal Oncology · doi:10.21037/jgo.2016.08.06 · Cited by 91
Catto, J. W. F., Xinarianos, G., Burton, J. L., Meuth, M., & Hamdy, F. C. (2003) · International Journal of Cancer · doi:10.1002/ijc.11109 · Cited by 87
Woerner, S. M., Yuan, Y. P., Benner, A., Korff, S., Doeberitz, M. V. K., & Peer Bork, B. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp839 · Cited by 86
Sinicrope, F. A., Rego, R. L., Foster, N. R., Sargent, D. J., Windschitl, H. E., Burgart, L. J., Witzig, T. E., & Thibodeau, S. N. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00845.x · Cited by 84
Tejpar, S., Saridaki, Z., Delorenzi, M., Bosman, F. T., & Roth, A. (2011) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djr170 · Cited by 84
Lee, K. S., Kwak, Y., Ahn, S., Shin, E. H., Oh, H., Kim, D., Kang, S., Choe, G., Kim, W. H., & Lee, H. S. (2017) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-017-1999-6 · Cited by 84
Takamochi, K., Takahashi, F., Suehara, Y., Sato, E., Kohsaka, S., Hayashi, T., Kitano, S., Uneno, T., Kojima, S., Takeuchi, K., et al. (2017) · Lung Cancer · doi:10.1016/j.lungcan.2017.05.016 · Cited by 78
Fujiyoshi, K., Yamamoto, G., Takahashi, A., Arai, Y., Yamada, M., Kakuta, M., Yamaguchi, K., Akagi, Y., Nishimura, Y., Sakamoto, H., et al. (2016) · Oncology Reports · doi:10.3892/or.2016.5323 · Cited by 76
Schellens, J. H. M., Marabelle, A., Zeigenfuss, S., Ding, J., Pruitt, S. K., & Chung, H. C. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.35.15_suppl.5514 · Cited by 75
Laghi, L., Beghelli, S., Spinelli, A., Bianchi, P. P., Basso, G., Caro, G. D., Brecht, A., Celesti, G., Turri, G., Bersani, S., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046002 · Cited by 72
Suh, W., Tafuri, A., Berg-Brown, N. N., Shahinian, A., Plyte, S., Duncan, G. S., Okada, H., Wakeham, A. C., Odermatt, B., Ohashi, P. S., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.10.5917 · Cited by 68
Hereditary nonpolyposis colorectal cancer (HNPCC)
Lynch, H. T. (1999) · Cytogenetic and Genome Research · doi:10.1159/000015365 · Cited by 68
Maby, P., Galon, J., & Latouche, J. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1115943 · Cited by 62
Chang, D. K., Metzgar, D., Wills, C., & Boland, C. R. (2001) · Genome Research · doi:10.1101/gr.186301 · Cited by 59
Burger, M., Denzinger, S., Hammerschmied, C. G., Tannapfel, A., Obermann, E. C., Wieland, W. F., Hartmann, A., & Stoehr, R. (2006) · Journal of Molecular Medicine · doi:10.1007/s00109-006-0074-0 · Cited by 58
Viana‐Pereira, M., Lee, A., Popov, S., Bax, D. A., Al‐Sarraj, S., Bridges, L., Stávale, J. N., Hargrave, D. R., Jones, C., & Reis, R. M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020588 · Cited by 57
Resnick, K. E., Frankel, W. L., Morrison, C. D., Fowler, J. M., Copeland, L. J., Stephens, J. A., Kim, K. H., & Cohn, D. E. (2010) · Gynecologic Oncology · doi:10.1016/j.ygyno.2009.12.028 · Cited by 53
New use of microsatellite instability analysis in endometrial cancer
Kunitomi, H., Banno, K., Yanokura, M., Takeda, T., Iijima, M., Nakamura, K., Iida, M., Adachi, M., Watanabe, K., Matoba, Y., et al. (2017) · Oncology Letters · doi:10.3892/ol.2017.6640 · Cited by 51
MutLα: At the Cutting Edge of Mismatch Repair
Jiricny, J. (2006) · Cell · doi:10.1016/j.cell.2006.07.003 · Cited by 48
Naboush, A., Roman, C. A. J., & Shapira, I. (2017) · Journal of Investigative Medicine · doi:10.1136/jim-2016-000342 · Cited by 48
Snowsill, T., Huxley, N., Hoyle, M., Jones-Hughes, T., Coelho, H. F., Cooper, C., Frayling, I. M., & Hyde, C. (2015) · BMC Cancer · doi:10.1186/s12885-015-1254-5 · Cited by 47
Defective DNA mismatch repair in long-term (≥ 3 years) survivors with pancreatic cancer
Maple, J. T., Smyrk, T. C., Boardman, L. A., Johnson, R., Thibodeau, S. N., Chari, S. T., & Real, F. X. (2005) · Pancreatology · doi:10.1159/000085275 · Cited by 46
The CpG Island Methylator Phenotype in Colorectal Cancer
Samowitz, W. S. (2007) · Journal of Molecular Diagnostics · doi:10.2353/jmoldx.2007.070031 · Cited by 46
Grassi, A., Segala, C., Iannelli, F., Volorio, S., Bertario, L., Radice, P., Bernard, L., & Ciccarelli, F. D. (2010) · PLoS Biology · doi:10.1371/journal.pbio.1000275 · Cited by 44
Common genetic variation and survival after colorectal cancer diagnosis: a genome-wide analysis
Phipps, A. I., Passarelli, M. N., Chan, A. T., Harrison, T. A., Jeon, J., Hutter, C. M., Berndt, S. I., Brenner, H., Caan, B. J., Campbell, P. T., et al. (2015) · Carcinogenesis · doi:10.1093/carcin/bgv161 · Cited by 43
Haraldsdóttir, S., Roth, R. M., Pearlman, R., Hampel, H., Arnold, C. A., & Frankel, W. L. (2015) · Familial Cancer · doi:10.1007/s10689-015-9856-2 · Cited by 43
Cloyd, J. M., Chun, Y. S., Ikoma, N., Vauthey, J., Aloia, T., Cuddy, A., Rodrı́guez-Bigas, M. A., & You, Y. N. (2017) · Journal of Gastrointestinal Cancer · doi:10.1007/s12029-017-0040-9 · Cited by 42
Hechtman, J. F., Middha, S., Stadler, Z. K., Zehir, A., Berger, M. F., Vakiani, E., Weiser, M. R., Ladanyi, M., Saltz, L. B., Klimstra, D. S., et al. (2017) · Familial Cancer · doi:10.1007/s10689-017-9993-x · Cited by 41
Palmieri, G., Ascierto, P. A., Cossu, A., Colombino, M., Casula, M., Botti, G., Lissia, A., Tanda, F., & Castello, G. (2003) · Melanoma Research · doi:10.1097/00008390-200304000-00009 · Cited by 36
Checkpoint inhibition in pediatric hematologic malignancies
Davis, K. L., Agarwal, A. M., & Verma, A. R. (2017) · Pediatric Hematology and Oncology · doi:10.1080/08880018.2017.1383542 · Cited by 36
The role of programmed cell death‐1 (PD‐1) and its ligands in pediatric cancer
van Dam, L. S., de Zwart, V., & Meyer‐Wentrup, F. A. G. (2014) · Pediatric Blood & Cancer · doi:10.1002/pbc.25284 · Cited by 35
Jung, J., Kang, Y., Lee, Y. J., Kim, E., Ahn, B., Lee, E., Kim, J. Y., Lee, J. H., Lee, Y., Kim, C. H., et al. (2017) · Journal of Pathology and Translational Medicine · doi:10.4132/jptm.2016.12.09 · Cited by 35
Cited by
Luchini, C., Bibeau, F., Ligtenberg, M. J. L., Singh, N., Nottegar, A., Bosse, T., Miller, R., Riaz, N., Douillard, J.-Y., Andre, F., et al. (2019) · Annals of Oncology · doi:10.1093/annonc/mdz116 · Cited by 1,041
Quantitative Proteomics of the Cancer Cell Line Encyclopedia
Nusinow, D. P., Szpyt, J., Ghandi, M., Rose, C. M., McDonald, E. R., Kalocsay, M., Jané-Valbuena, J., Gelfand, E., Schweppe, D. K., Jedrychowski, M., et al. (2020) · Cell · doi:10.1016/j.cell.2019.12.023 · Cited by 957
“Additionally, these tumors have increased levels of neoantigens making them attractive for immunooncology therapies (Baretti and Le, 2018).”
The multi-factorial nature of clinical multidrug resistance in cancer
Assaraf, Y. G., Brozovic, A., Gonçalves, A. C., Jurkovicova, D., Linē, A., Machuqueiro, M., Saponara, S., Sarmento-Ribeiro, A. B., Xavier, C. P. R., & Vasconcelos, M. H. (2019) · Drug Resistance Updates · doi:10.1016/j.drup.2019.100645 · Cited by 528
Sun, J.-Y., Zhang, D., Wu, S., Xu, M., Zhou, X., Lu, X.-J., & Ji, J. (2020) · Biomarker Research · doi:10.1186/s40364-020-00212-5 · Cited by 279
Mismatch Repair Pathway, Genome Stability and Cancer
Pećina-Šlaus, N., Kafka, A., Salamon, I., & Bukovac, A. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.00122 · Cited by 278
Metadata
- Authors
- Baretti, M., & Le, D. T.
- Venue
- Pharmacology & Therapeutics
- Publisher
- Elsevier BV
- Published
- 2018-09
- Volume
- 189
- Pages
- 45-62
- ISSN
- 0163-7258 (ISSN-L)
- OpenAlex
- W2796494201
- Cited by
- 556
- References
- 210
- FWCI
- 24.10
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.